| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allocation Based on Virtual Crossmatch Alone: Not Yet Ready for Primetime
|
Kher, A.
|
|
|
16 |
12 |
p. 3577
|
artikel
|
| 2 |
American Journal of Transplantation: Volume 16, Number 12, December 2016
|
|
|
|
16 |
12 |
p. i
|
artikel
|
| 3 |
Anti-LG3 Antibodies Aggravate Renal Ischemia–Reperfusion Injury and Long-Term Renal Allograft Dysfunction
|
Yang, B.
|
|
|
16 |
12 |
p. 3416-3429
|
artikel
|
| 4 |
APOL1-Associated End-Stage Renal Disease in a Living Kidney Transplant Donor
|
Zwang, N.A.
|
|
|
16 |
12 |
p. 3568-3572
|
artikel
|
| 5 |
A Potential Solution to Make the Best Use of a Living Donor–Deceased Donor List Exchange
|
Kute, V.B.
|
|
|
16 |
12 |
p. 3580
|
artikel
|
| 6 |
A Smartphone App for Increasing Live Organ Donation
|
Kumar, K.
|
|
|
16 |
12 |
p. 3548-3553
|
artikel
|
| 7 |
Azathioprine and Risk of Skin Cancer in Organ Transplant Recipients: Systematic Review and Meta-Analysis
|
Jiyad, Z.
|
|
|
16 |
12 |
p. 3490-3503
|
artikel
|
| 8 |
Biomarkers of Tolerance in Kidney Transplantation: Are We Predicting Tolerance or Response to Immunosuppressive Treatment?
|
Rebollo-Mesa, I.
|
|
|
16 |
12 |
p. 3443-3457
|
artikel
|
| 9 |
Bone Marrow Cell Transplant From Donors With Cardiovascular Risk Factors Increases the Pro-atherosclerotic Phenotype in the Recipients
|
Bejar, M.T.
|
|
|
16 |
12 |
p. 3392-3403
|
artikel
|
| 10 |
Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients
|
Adebiyi, O.O.
|
|
|
16 |
12 |
p. 3458-3467
|
artikel
|
| 11 |
Coccidioidomycosis Transmission Through Organ Transplantation: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee
|
Kusne, S.
|
|
|
16 |
12 |
p. 3562-3567
|
artikel
|
| 12 |
Contaminated Devices Putting Open-Heart Surgery Patients at Risk
|
|
|
|
16 |
12 |
p. 3573
|
artikel
|
| 13 |
DAMP—Induced Allograft and Tumor Rejection: The Circle Is Closing
|
Land, W.G.
|
|
|
16 |
12 |
p. 3322-3337
|
artikel
|
| 14 |
First-Degree Living-Related Donor Liver Transplantation in Autoimmune Liver Diseases
|
Aravinthan, A.D.
|
|
|
16 |
12 |
p. 3512-3521
|
artikel
|
| 15 |
Health Insurance Trends in United States Living Kidney Donors (2004 to 2015)
|
Rodrigue, J.R.
|
|
|
16 |
12 |
p. 3504-3511
|
artikel
|
| 16 |
Ionic Checkpoint: Potassium-Driven T Cell Immunosuppression
|
Alegre, Maria-Luisa
|
|
|
16 |
12 |
p. 3313
|
artikel
|
| 17 |
Late Choledochojejunostomy Dysfunction After Liver Transplantation for Primary Sclerosing Cholangitis
|
Zamora-Valdes, D.
|
|
|
16 |
12 |
p. 3574-3576
|
artikel
|
| 18 |
Liver Allograft Provides Immunoprotection for the Cardiac Allograft in Combined Heart–Liver Transplantation
|
Wong, T.W.
|
|
|
16 |
12 |
p. 3522-3531
|
artikel
|
| 19 |
Living Organ Donation by Minors: An Analysis of the Regulations in European Union Member States
|
Thys, K.
|
|
|
16 |
12 |
p. 3554-3561
|
artikel
|
| 20 |
Measuring What Matters
|
Axelrod, D.A.
|
|
|
16 |
12 |
p. 3315-3317
|
artikel
|
| 21 |
Micro and Nano Material Carriers for Immunomodulation
|
Bracho-Sanchez, E.
|
|
|
16 |
12 |
p. 3362-3370
|
artikel
|
| 22 |
NIH to Lift Moratorium on Chimera Research Funding
|
Pullen, Lara C.
|
|
|
16 |
12 |
p. 3311-3312
|
artikel
|
| 23 |
Patterns of End-Stage Renal Disease Caused by Diabetes, Hypertension, and Glomerulonephritis in Live Kidney Donors
|
Anjum, S.
|
|
|
16 |
12 |
p. 3540-3547
|
artikel
|
| 24 |
Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study
|
Montgomery, R.A.
|
|
|
16 |
12 |
p. 3468-3478
|
artikel
|
| 25 |
Potential Implications of Recent and Proposed Changes in the Regulatory Oversight of Solid Organ Transplantation in the United States
|
Kasiske, B.L.
|
|
|
16 |
12 |
p. 3371-3377
|
artikel
|
| 26 |
Recipient Outcomes Following Transplantation of Allografts From Live Kidney Donors Who Subsequently Developed End-Stage Renal Disease
|
Muzaale, A.D.
|
|
|
16 |
12 |
p. 3532-3539
|
artikel
|
| 27 |
Recipients Inherit a Cardiovascular Risk Factor From Bone Marrow Donors: Implications for Screening of Donors?
|
Dai, Z.
|
|
|
16 |
12 |
p. 3318-3319
|
artikel
|
| 28 |
Reply to “Allocation Based on Virtual Crossmatch Alone: Not Yet Ready for Primetime”
|
Johnson, C.
|
|
|
16 |
12 |
p. 3578-3579
|
artikel
|
| 29 |
Risk of Renal Cell Carcinoma Among Kidney Transplant Recipients in the United States
|
Karami, S.
|
|
|
16 |
12 |
p. 3479-3489
|
artikel
|
| 30 |
Signatures of Tolerance or Immunosuppression?
|
Markmann, J.F.
|
|
|
16 |
12 |
p. 3320-3321
|
artikel
|
| 31 |
The Ethics of Promoting Living Kidney Donation Using Nonargumentative Influence: Applications, Concerns, and Future Directions
|
Allen, M.B.
|
|
|
16 |
12 |
p. 3378-3384
|
artikel
|
| 32 |
The Immunosuppressive Effect of CTLA4 Immunoglobulin Is Dependent on Regulatory T Cells at Low But Not High Doses
|
Schwarz, C.
|
|
|
16 |
12 |
p. 3404-3415
|
artikel
|
| 33 |
The Long-Term Follow-up and Support for Living Organ Donors: A Center-Based Initiative Founded on Developing a Community of Living Donors
|
Kulkarni, S.
|
|
|
16 |
12 |
p. 3385-3391
|
artikel
|
| 34 |
Transcriptomic Signature of the CD
|
Bigot, J.
|
|
|
16 |
12 |
p. 3430-3442
|
artikel
|
| 35 |
Transplantation and Damage-Associated Molecular Patterns (DAMPs)
|
Land, W.G.
|
|
|
16 |
12 |
p. 3338-3361
|
artikel
|
| 36 |
We Need to Take the Next Step
|
Melcher, M.L.
|
|
|
16 |
12 |
p. 3581-3582
|
artikel
|
Tijdschrift beschrijving